Access cutting-edge pulmonary embolism treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access pulmonary embolism specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary embolism treatment provided free
PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.
Sponsor: NYU Langone Health
Check if you qualify for this pulmonary embolism clinical trial in Washington Dc, DC
If you're searching for pulmonary embolism treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary embolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.